Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hagan

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Addiction (Abingdon, England)|December 1, 1993
An interview study of participants in the Tacoma, Washington, syringe exchangeH Hagan, D C Des Jarlais, D Purchase, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|March 31, 2000
Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programsH Hagan, J P McGough, H Thiede, et al.
International Journal of STD & AIDS|September 1, 2006
Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug usersZ P Vassilev, H Hagan, A Lyubenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2021
Mapping pollution exposure and chemistry during an extreme air quality event (the 2018 Kīlauea eruption) using a low-cost sensor networkBen Crawford, David H Hagan, Ilene Grossman, et al.
Advances in Preventive Medicine|July 11, 2013
30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject DrugsD C Des Jarlais, S Pinkerton, H Hagan, et al.
AIDS and Behavior|November 26, 2013
Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York CityD C Des Jarlais, K Arasteh, C McKnight, et al.
Lancet (London, England)|May 21, 1999
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trialD C Des Jarlais, D Paone, J Milliken, et al.
JAMA|October 18, 1995
Maintaining low HIV seroprevalence in populations of injecting drug usersD C Des Jarlais, H Hagan, S R Friedman, et al.
Journal of Medical Virology|June 26, 2001
Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIAP D Swenson, C Van Geyt, E R Alexander, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug usersSteffanie A Strathdee, M Latka, J Campbell, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Addiction (Abingdon, England)|December 1, 1993
An interview study of participants in the Tacoma, Washington, syringe exchangeH Hagan, D C Des Jarlais, D Purchase, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|March 31, 2000
Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programsH Hagan, J P McGough, H Thiede, et al.
International Journal of STD & AIDS|September 1, 2006
Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug usersZ P Vassilev, H Hagan, A Lyubenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2021
Mapping pollution exposure and chemistry during an extreme air quality event (the 2018 Kīlauea eruption) using a low-cost sensor networkBen Crawford, David H Hagan, Ilene Grossman, et al.
Advances in Preventive Medicine|July 11, 2013
30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject DrugsD C Des Jarlais, S Pinkerton, H Hagan, et al.
AIDS and Behavior|November 26, 2013
Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York CityD C Des Jarlais, K Arasteh, C McKnight, et al.
Lancet (London, England)|May 21, 1999
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trialD C Des Jarlais, D Paone, J Milliken, et al.
JAMA|October 18, 1995
Maintaining low HIV seroprevalence in populations of injecting drug usersD C Des Jarlais, H Hagan, S R Friedman, et al.
Journal of Medical Virology|June 26, 2001
Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIAP D Swenson, C Van Geyt, E R Alexander, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug usersSteffanie A Strathdee, M Latka, J Campbell, et al.
Pageof 4